Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Type 2 diabetes remission trajectories and variation in risk of diabetes complications: A population-based cohort study

Open access
Dambha-Miller, Hajira, Hounkpatin, Hilda O., Stuart, Beth, Farmer, Andrew, Griffin, Simon · 2023 · PLOS ONE

Abstract

Biochemical remission of type 2 diabetes is achievable through dietary changes, physical activity and subsequent weight loss. We aim to identify distinct diabetes remission trajectories in a large population-based cohort over seven-years follow-up and to examine associations between remission trajectories and diabetes complications. Group-based trajectory modelling examined longitudinal patterns of HbA 1c level (adjusting for remission status) over time. Multivariable Cox models quantified the association between each remission trajectory and microvascular complications, macrovascular complications, cardiovascular (CVD) events and all-cause mortality. Four groups were assigned. Group 1 (8,112 [13.5%]; achieving HbA 1c <48 mmol/mol (6.5%) followed by increasing HbA 1c levels); Group 2 (6,369 [10.6%]; decreasing HbA 1c levels >48 mmol/mol (6.5%)); Group 3 (36,557 [60.6%]; stable high HbA 1c levels); Group 4 (9,249 [15.3%]; stable low HbA 1c levels (<48mmol/mol or <6.5%)). Compared to Group 3, Groups 1 and 4 had lower risk of microvascular complications (aHRs (95% CI): 0.65 (0.61–0.70), p-value <0.001;0.59 (0.55–0.64) p-value<0.001, respectively)), macrovascular complications (aHRs (95% CI): 0.83 (0.75–0.92), p-value<0.001; 0.66 (0.61–0.71), p-value<0.001) and CVD events (aHRs (95% CI): 0.74(0.67–0.83), p-value<0.001; 0.67(0.61–0.73), p-vlaue<0.001). Risk of CVD outcomes were similar for Groups 2 and 3. Compared to Group 3, Group 1 (aHR: 0.82(95% CI: 0.76–0.89)) had lower risk of mortality, but Group 4 had higher risk of mortality (aHR: 1.11(95% CI: 1.03–1.19)). Risk of CVD outcomes vary by pattern of remission over time, with lowest risk for those in remission longer. People who achieve remission, even for shorter periods of time, continue to benefit from this lower exposure to hyperglycaemia, which may, in turn, lower the risk of CVD outcomes including mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0290791

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Mean HbA1c level for each remission group over seven-year follow-up within the CHIA type 2 diabetes cohort (n = 60,287).
Fig 1 Mean HbA1c level for each remission group over seven-year follow-up within the CHIA type 2 diabetes cohort (n = 60,287).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 15

Metadata

Authors
Dambha-Miller, H., Hounkpatin, H. O., Stuart, B., Farmer, A., & Griffin, S.
Affiliations
  • University of Southampton (GB)
  • University of Oxford (GB)
  • University of Cambridge (GB)
Corresponding author
Hounkpatin, Hilda O.
Venue
PLOS ONE
Published
2023-08-29
Volume
18
Issue
8
Pages
e0290791
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4386246509
Cited by
13
References
19
Citations by year
2026: 4 · 2025: 5 · 2024: 4
FWCI
2.67
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • NIHR School for Primary Care Research (SPCR2014-10043)
  • NIHR Oxford Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes remission, HbA1c, microvascular complications, macrovascular complications, cardiovascular events, all-cause mortality, remission maintenance, glycemic control, weight loss, lifestyle intervention, diabetes complications risk, group-based trajectory modeling, UK Biobank
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Hyperglycemia, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 2 diabetes remission trajectories and variation in risk of diabetes complications: A population-based cohort study. https://app.cochat.ai/papers/10.1371/journal.pone.0290791
The paper
Dambha-Miller, H., Hounkpatin, H. O., Stuart, B., Farmer, A., & Griffin, S. (2023). Type 2 diabetes remission trajectories and variation in risk of diabetes complications: A population-based cohort study. PLOS ONE. https://doi.org/10.1371/journal.pone.0290791

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.